Drreddys Laboratories reported INR101.4B in Trade Debtors for its fiscal quarter ending in September of 2026.





Trade Debtors Change Date
ANI Pharmaceuticals USD 304.45M 29.98M Sep/2026
Aurora Cannabis CAD 41.09M 3.49M Jun/2026
Bayer EUR 17.41B 1.29B Sep/2026
Canopy Growth CAD 42.59M 6.3M Jun/2026
Cipla INR 65.92B 3.73B Sep/2026
Corcept Therapeutics USD 111.06M 34.14M Sep/2026
Drreddys Laboratories INR 101.4B 21.77B Sep/2026
GlaxoSmithKline GBP 8.52B 451M Sep/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Lonza CHF 1.78B 55M Dec/2025
Novartis USD 9.96B 109M Sep/2026
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 187.36M 4.56M Jun/2026
Richter Gedeon HUF 254.49B 4.24B Jun/2026
Sun Pharmaceuticals INR 186.47B 24.38B Sep/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
Teva Pharmaceutical Industries USD 3.84B 344M Sep/2026